Annual SG&A
$901.89 M
+$51.14 M+6.01%
31 December 2023
Summary:
IDEXX Laboratories annual selling, general & administrative expenses is currently $901.89 million, with the most recent change of +$51.14 million (+6.01%) on 31 December 2023. During the last 3 years, it has risen by +$166.62 million (+22.66%). IDXX annual SG&A is now at all-time high.IDXX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$238.17 M
-$61.74 M-20.59%
30 September 2024
Summary:
IDEXX Laboratories quarterly selling, general & administrative expenses is currently $238.17 million, with the most recent change of -$61.74 million (-20.59%) on 30 September 2024. Over the past year, it has increased by +$13.44 million (+5.98%). IDXX quarterly SG&A is now -20.59% below its all-time high of $299.91 million, reached on 30 June 2024.IDXX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$19.12 B
+$866.24 M+4.74%
30 September 2024
Summary:
IDEXX Laboratories TTM selling, general & administrative expenses is currently $19.12 billion, with the most recent change of +$866.24 million (+4.74%) on 30 September 2024. Over the past year, it has increased by +$18.24 billion (+2054.09%). IDXX TTM SG&A is now at all-time high.IDXX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.0% | +6.0% | +2054.1% |
3 y3 years | +22.7% | +15.3% | +2383.4% |
5 y5 years | +42.6% | +39.4% | +2824.1% |
IDXX Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +22.7% | -20.6% | +15.3% | at high | +93.3% |
5 y | 5 years | at high | +42.6% | -20.6% | +54.2% | at high | +258.1% |
alltime | all time | at high | +5872.8% | -20.6% | +6337.0% | at high | >+9999.0% |
IDEXX Laboratories Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $238.17 M(-20.6%) | $1.01 B(+1.4%) |
June 2024 | - | $299.91 M(+24.2%) | $995.17 M(+7.5%) |
Mar 2024 | - | $241.48 M(+5.4%) | $925.46 M(+2.6%) |
Dec 2023 | $901.89 M(+6.0%) | $229.05 M(+1.9%) | $901.89 M(+1.6%) |
Sept 2023 | - | $224.73 M(-2.4%) | $887.82 M(+1.2%) |
June 2023 | - | $230.20 M(+5.6%) | $876.87 M(+2.2%) |
Mar 2023 | - | $217.91 M(+1.4%) | $858.42 M(+0.9%) |
Dec 2022 | $850.75 M(+6.8%) | $214.98 M(+0.6%) | $850.75 M(+0.4%) |
Sept 2022 | - | $213.78 M(+1.0%) | $847.70 M(+0.9%) |
June 2022 | - | $211.75 M(+0.7%) | $840.44 M(+2.4%) |
Mar 2022 | - | $210.24 M(-0.8%) | $821.05 M(+3.1%) |
Dec 2021 | $796.39 M(+8.3%) | $211.92 M(+2.6%) | $796.39 M(+3.4%) |
Sept 2021 | - | $206.53 M(+7.4%) | $770.10 M(-0.9%) |
June 2021 | - | $192.36 M(+3.7%) | $776.80 M(+5.1%) |
Mar 2021 | - | $185.58 M(-0.0%) | $738.89 M(+0.5%) |
Dec 2020 | $735.27 M(+8.2%) | $185.63 M(-12.9%) | $735.27 M(+0.7%) |
Sept 2020 | - | $213.23 M(+38.1%) | $730.00 M(+6.2%) |
June 2020 | - | $154.45 M(-15.1%) | $687.65 M(-1.0%) |
Mar 2020 | - | $181.96 M(+0.9%) | $694.52 M(+2.2%) |
Dec 2019 | $679.51 M(+7.5%) | $180.36 M(+5.5%) | $679.51 M(+3.9%) |
Sept 2019 | - | $170.89 M(+5.9%) | $654.03 M(+1.8%) |
June 2019 | - | $161.32 M(-3.4%) | $642.24 M(+0.6%) |
Mar 2019 | - | $166.94 M(+7.8%) | $638.26 M(+0.9%) |
Dec 2018 | $632.34 M(+9.9%) | $154.88 M(-2.7%) | $632.34 M(+1.4%) |
Sept 2018 | - | $159.10 M(+1.1%) | $623.33 M(+2.1%) |
June 2018 | - | $157.34 M(-2.3%) | $610.23 M(+2.4%) |
Mar 2018 | - | $161.03 M(+10.4%) | $596.05 M(+3.6%) |
Dec 2017 | $575.17 M(+9.7%) | $145.86 M(-0.1%) | $575.17 M(+2.6%) |
Sept 2017 | - | $146.00 M(+2.0%) | $560.70 M(+2.4%) |
June 2017 | - | $143.15 M(+2.1%) | $547.29 M(+2.3%) |
Mar 2017 | - | $140.16 M(+6.7%) | $535.11 M(+2.1%) |
Dec 2016 | $524.08 M(+8.6%) | $131.38 M(-0.9%) | $524.08 M(+1.2%) |
Sept 2016 | - | $132.60 M(+1.2%) | $517.98 M(+2.6%) |
June 2016 | - | $130.97 M(+1.4%) | $504.69 M(+2.2%) |
Mar 2016 | - | $129.12 M(+3.1%) | $493.85 M(+2.4%) |
Dec 2015 | $482.46 M(+5.4%) | $125.29 M(+5.0%) | $482.46 M(+0.6%) |
Sept 2015 | - | $119.31 M(-0.7%) | $479.67 M(+0.6%) |
June 2015 | - | $120.14 M(+2.0%) | $476.67 M(+2.2%) |
Mar 2015 | - | $117.73 M(-3.9%) | $466.40 M(+1.9%) |
Dec 2014 | $457.60 M(+14.0%) | $122.50 M(+5.3%) | $457.60 M(+4.0%) |
Sept 2014 | - | $116.30 M(+5.9%) | $439.94 M(+4.2%) |
June 2014 | - | $109.87 M(+0.9%) | $422.37 M(+3.2%) |
Mar 2014 | - | $108.94 M(+3.9%) | $409.26 M(+2.0%) |
Dec 2013 | $401.35 M(+13.2%) | $104.84 M(+6.2%) | $401.35 M(+5.3%) |
Sept 2013 | - | $98.73 M(+2.0%) | $381.08 M(+3.1%) |
June 2013 | - | $96.75 M(-4.2%) | $369.73 M(+2.2%) |
Mar 2013 | - | $101.03 M(+19.5%) | $361.79 M(+2.0%) |
Dec 2012 | $354.57 M(+6.1%) | $84.57 M(-3.2%) | $354.57 M(+0.3%) |
Sept 2012 | - | $87.37 M(-1.6%) | $353.38 M(+1.2%) |
June 2012 | - | $88.81 M(-5.3%) | $349.17 M(+1.4%) |
Mar 2012 | - | $93.81 M(+12.5%) | $344.47 M(+3.1%) |
Dec 2011 | $334.24 M(+9.2%) | $83.38 M(+0.3%) | $334.24 M(+2.1%) |
Sept 2011 | - | $83.17 M(-1.1%) | $327.35 M(+2.5%) |
June 2011 | - | $84.11 M(+0.6%) | $319.37 M(+2.2%) |
Mar 2011 | - | $83.58 M(+9.3%) | $312.50 M(+2.1%) |
Dec 2010 | $306.14 M(+7.3%) | $76.49 M(+1.7%) | $306.14 M(+1.2%) |
Sept 2010 | - | $75.19 M(-2.7%) | $302.43 M(+1.9%) |
June 2010 | - | $77.24 M(+0.0%) | $296.93 M(+1.6%) |
Mar 2010 | - | $77.22 M(+6.1%) | $292.36 M(+2.5%) |
Dec 2009 | $285.19 M(-0.5%) | $72.78 M(+4.4%) | $285.19 M(+1.9%) |
Sept 2009 | - | $69.69 M(-4.1%) | $279.90 M(-0.5%) |
June 2009 | - | $72.67 M(+3.7%) | $281.44 M(-0.5%) |
Mar 2009 | - | $70.05 M(+3.8%) | $282.87 M(-1.3%) |
Dec 2008 | $286.64 M(+10.2%) | $67.49 M(-5.3%) | $286.64 M(-0.4%) |
Sept 2008 | - | $71.23 M(-3.9%) | $287.88 M(+2.2%) |
June 2008 | - | $74.09 M(+0.4%) | $281.75 M(+3.5%) |
Mar 2008 | - | $73.82 M(+7.4%) | $272.09 M(+4.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2007 | $260.00 M(+31.3%) | $68.73 M(+5.6%) | $260.00 M(+6.5%) |
Sept 2007 | - | $65.10 M(+1.0%) | $244.12 M(+6.6%) |
June 2007 | - | $64.44 M(+4.4%) | $229.06 M(+7.4%) |
Mar 2007 | - | $61.73 M(+16.8%) | $213.34 M(+7.8%) |
Dec 2006 | $197.98 M(+18.8%) | $52.85 M(+5.6%) | $197.98 M(+4.6%) |
Sept 2006 | - | $50.04 M(+2.7%) | $189.23 M(+5.2%) |
June 2006 | - | $48.72 M(+5.1%) | $179.85 M(+4.1%) |
Mar 2006 | - | $46.37 M(+5.2%) | $172.82 M(+3.7%) |
Dec 2005 | $166.62 M(+22.9%) | $44.10 M(+8.4%) | $166.62 M(+4.9%) |
Sept 2005 | - | $40.66 M(-2.5%) | $158.79 M(+4.5%) |
June 2005 | - | $41.69 M(+3.8%) | $151.96 M(+6.6%) |
Mar 2005 | - | $40.17 M(+10.8%) | $142.52 M(+5.1%) |
Dec 2004 | $135.58 M(+15.3%) | $36.26 M(+7.2%) | $135.58 M(-0.1%) |
Sept 2004 | - | $33.83 M(+4.9%) | $135.78 M(+4.9%) |
June 2004 | - | $32.26 M(-2.9%) | $129.37 M(+4.2%) |
Mar 2004 | - | $33.23 M(-8.9%) | $124.14 M(+5.6%) |
Dec 2003 | $117.60 M(+20.5%) | $36.46 M(+32.9%) | $117.60 M(+12.5%) |
Sept 2003 | - | $27.43 M(+1.5%) | $104.57 M(+2.3%) |
June 2003 | - | $27.03 M(+1.3%) | $102.26 M(+3.6%) |
Mar 2003 | - | $26.68 M(+13.9%) | $98.70 M(+1.1%) |
Dec 2002 | $97.58 M(-0.8%) | $23.43 M(-6.7%) | $97.58 M(+1.2%) |
Sept 2002 | - | $25.12 M(+7.0%) | $96.38 M(+1.2%) |
June 2002 | - | $23.47 M(-8.2%) | $95.28 M(-3.4%) |
Mar 2002 | - | $25.56 M(+15.0%) | $98.66 M(+0.3%) |
Dec 2001 | $98.35 M(+2.8%) | $22.23 M(-7.5%) | $98.35 M(+1.2%) |
Sept 2001 | - | $24.02 M(-10.6%) | $97.14 M(+1.4%) |
June 2001 | - | $26.86 M(+6.4%) | $95.81 M(+1.3%) |
Mar 2001 | - | $25.25 M(+20.2%) | $94.58 M(-1.1%) |
Dec 2000 | $95.63 M(-2.3%) | $21.01 M(-7.4%) | $95.63 M(-0.9%) |
Sept 2000 | - | $22.69 M(-11.5%) | $96.52 M(-0.5%) |
June 2000 | - | $25.63 M(-2.6%) | $97.03 M(+0.1%) |
Mar 2000 | - | $26.30 M(+20.1%) | $96.90 M(-1.0%) |
Dec 1999 | $97.90 M(-12.0%) | $21.90 M(-5.6%) | $97.90 M(-3.5%) |
Sept 1999 | - | $23.20 M(-9.0%) | $101.50 M(-3.5%) |
June 1999 | - | $25.50 M(-6.6%) | $105.20 M(-3.6%) |
Mar 1999 | - | $27.30 M(+7.1%) | $109.10 M(-1.8%) |
Dec 1998 | $111.20 M(-4.2%) | $25.50 M(-5.2%) | $111.10 M(-2.2%) |
Sept 1998 | - | $26.90 M(-8.5%) | $113.60 M(-2.1%) |
June 1998 | - | $29.40 M(+0.3%) | $116.00 M(-0.8%) |
Mar 1998 | - | $29.30 M(+4.6%) | $116.90 M(+0.7%) |
Dec 1997 | $116.10 M(+8.1%) | $28.00 M(-4.4%) | $116.10 M(-8.7%) |
Sept 1997 | - | $29.30 M(-3.3%) | $127.20 M(+3.8%) |
June 1997 | - | $30.30 M(+6.3%) | $122.50 M(+6.2%) |
Mar 1997 | - | $28.50 M(-27.1%) | $115.30 M(+7.5%) |
Dec 1996 | $107.40 M(+66.3%) | $39.10 M(+58.9%) | $107.30 M(+24.6%) |
Sept 1996 | - | $24.60 M(+6.5%) | $86.10 M(+11.0%) |
June 1996 | - | $23.10 M(+12.7%) | $77.60 M(+9.6%) |
Mar 1996 | - | $20.50 M(+14.5%) | $70.80 M(+9.8%) |
Dec 1995 | $64.60 M(+53.1%) | $17.90 M(+11.2%) | $64.50 M(+10.6%) |
Sept 1995 | - | $16.10 M(-1.2%) | $58.30 M(+10.6%) |
June 1995 | - | $16.30 M(+14.8%) | $52.70 M(+12.6%) |
Mar 1995 | - | $14.20 M(+21.4%) | $46.80 M(+10.6%) |
Dec 1994 | $42.20 M(+2.4%) | $11.70 M(+11.4%) | $42.30 M(+3.2%) |
Sept 1994 | - | $10.50 M(+1.0%) | $41.00 M(-0.5%) |
June 1994 | - | $10.40 M(+7.2%) | $41.20 M(-0.5%) |
Mar 1994 | - | $9.70 M(-6.7%) | $41.40 M(+2.5%) |
Dec 1993 | $41.20 M(+50.4%) | $10.40 M(-2.8%) | $40.40 M(+7.2%) |
Sept 1993 | - | $10.70 M(+0.9%) | $37.70 M(+10.6%) |
June 1993 | - | $10.60 M(+21.8%) | $34.10 M(+11.8%) |
Mar 1993 | - | $8.70 M(+13.0%) | $30.50 M(+11.3%) |
Dec 1992 | $27.40 M(+81.5%) | $7.70 M(+8.5%) | $27.40 M(+13.7%) |
Sept 1992 | - | $7.10 M(+1.4%) | $24.10 M(+16.4%) |
June 1992 | - | $7.00 M(+25.0%) | $20.70 M(+19.0%) |
Mar 1992 | - | $5.60 M(+27.3%) | $17.40 M(+47.5%) |
Dec 1991 | $15.10 M | $4.40 M(+18.9%) | $11.80 M(+59.5%) |
Sept 1991 | - | $3.70 M(0.0%) | $7.40 M(+100.0%) |
June 1991 | - | $3.70 M | $3.70 M |
FAQ
- What is IDEXX Laboratories annual selling, general & administrative expenses?
- What is the all time high annual SG&A for IDEXX Laboratories?
- What is IDEXX Laboratories annual SG&A year-on-year change?
- What is IDEXX Laboratories quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly SG&A year-on-year change?
- What is IDEXX Laboratories TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for IDEXX Laboratories?
- What is IDEXX Laboratories TTM SG&A year-on-year change?
What is IDEXX Laboratories annual selling, general & administrative expenses?
The current annual SG&A of IDXX is $901.89 M
What is the all time high annual SG&A for IDEXX Laboratories?
IDEXX Laboratories all-time high annual selling, general & administrative expenses is $901.89 M
What is IDEXX Laboratories annual SG&A year-on-year change?
Over the past year, IDXX annual selling, general & administrative expenses has changed by +$51.14 M (+6.01%)
What is IDEXX Laboratories quarterly selling, general & administrative expenses?
The current quarterly SG&A of IDXX is $238.17 M
What is the all time high quarterly SG&A for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly selling, general & administrative expenses is $299.91 M
What is IDEXX Laboratories quarterly SG&A year-on-year change?
Over the past year, IDXX quarterly selling, general & administrative expenses has changed by +$13.44 M (+5.98%)
What is IDEXX Laboratories TTM selling, general & administrative expenses?
The current TTM SG&A of IDXX is $19.12 B
What is the all time high TTM SG&A for IDEXX Laboratories?
IDEXX Laboratories all-time high TTM selling, general & administrative expenses is $1.01 B
What is IDEXX Laboratories TTM SG&A year-on-year change?
Over the past year, IDXX TTM selling, general & administrative expenses has changed by +$18.24 B (+2054.09%)